Against the record
Versius, from CMR Surgical, is at stage 5 of 5 on our ladder: regulator-cleared or mass market. Cleared where approval applies, or widely sold. The latest milestone on its record is from 12 Oct 2026: Stryker agreed to invest about $400 million in CMR Surgical and become the only sales agent for Versius in the US. Stryker also got an option to buy the whole company later. The deal still needs regulatory approval.
This video comes from the maker's own channel, and makers show their robots at their best. The stage above comes from dated public records, not from the video.
From the video's description
Transforming Surgery. For Good. cmrsurgical.com Connect with us: Twitter: https://twitter.com/CMRSurgical Instagram: https://www.instagram.com/cmrsurgical/ Facebook: https://www.facebook.com/CMRSurgical/ https://www.linkedin.com/company/cmrsurgical/…
Written by CMR Surgical on YouTube.
More videos of Versius
What if surgical robots could help to anticipate, plan and adapt in order to support surgeons?
For surgeons, access begins with freedom of movement
For hospitals, access means more than technology—it means adaptability.
Built on a foundation of global clinical experience
What if access to robotic surgery was no longer limited by space, cost or constraints?
What if a robotic platform truly gave you the freedom of access?